New gel aims to boost knee therapy results
NCT ID NCT07308470
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a gel containing etodolac, applied to the skin over the knee, can improve pain and function when added to standard physiotherapy. Thirty people with mild to moderate knee osteoarthritis will receive either physiotherapy alone or physiotherapy plus the gel for four weeks. The goal is to see if the combination works better than physiotherapy alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 45 and 60 years. Mild to moderate unilateral knee osteoarthritis (Kellgren-Lawrence grades II-III). Ability to walk independently without assistive devices. Body Mass Index (BMI) \< 30 kg/m². No participation in resistance training in the 3 months prior to enrollment. Referred by an orthopedic surgeon and diagnosed based on clinical and radiological examination. Exclusion Criteria: * Severe or bilateral knee osteoarthritis (Kellgren-Lawrence grade IV). Congenital or acquired inflammatory, rheumatic, or neurological disorders affecting the knee. Repeated treatment with steroids or secondary knee OA. History of joint replacement surgery in the knee or hip. Cardiovascular or neuromuscular disorders. Diabetes mellitus. Psychiatric disorders.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Pharos University-Faculty of Physical Therapy
Alexandria, 21614, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight
- Can shockwave plus injections quiet knee arthritis pain?